Dallas, TX -- (SBWire) -- 10/07/2014 --The global molecular diagnostics market is estimated to reach $7,956.9 million by 2018, at a CAGR of 9.7% during the forecast period (2013–2018). The factors driving the growth of this market include the increasing infectious diseases, rising incidences of cancer, genetic disorders, and blood screening. The factors restraining this market include the economic downturn and saturation and the unstable reimbursement regulations in developed countries.
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html
The molecular diagnostics market is categorized on the basis of application, technology, end user, product, and geography. On the basis of application, infectious diseases were the leading market segment, in 2013. Under this segment the CT/NG sub-segment contributed to the maximum share of the market. The MRSA sub-segment will be the fastest growing segment by 2018. The major factor that drives the growth of this segment is the rise in the population size of the patients affected by the infectious diseases.
On the basis of technology, PCR was the fastest growing segment and is expected to grow further within the forecast period. This growth can be attributed to the dominant nature and acceptance of PCR over other technologies. Microarray technology is expected to drive the market at the highest CAGR in the forecast period.
Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=833
On the basis of end user, hospital segment showed the highest market share. This can be attributed to the growing population that gives rise to the awareness regarding various technologies available in the molecular diagnostics market. The reference laboratory segment is expected to grow at the highest CAGR in the forecasted period.
The product segment of the molecular diagnostics market comprises of instruments, reagents, and services and software. The reagents segment accounted for the highest market share and is expected to grow at a rapid pace in the forecasted period. The instruments segment will show a moderate growth as compared to the reagents segment, in the forecasted period.
Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=833
In 2013, North America accounted for the largest share in the market and is expected to grow from 2013 to 2018, at a higher CAGR than Europe. This growth can be attributed to the rise in the infectious diseases, cancer cases and the increasing incidence of lifestyle diseases. Europe accounted for the second largest market share in 2013; however, in the forecast period the growth of this region will be slow. Asia, on the other hand, will be the main focus of the market in the coming five years and will register higher growth rates for all its segments. The vast population size in countries such as India and China and the improved purchasing power of the rising middle class will drive the growth of this region.
The key players in the molecular diagnostics market are Roche Diagnostics (Switzerland), Hologic Gen-Probe (U.S.), QIAGEN (Netherlands), Becton, Dickinson & Company (U.S.), Siemens Healthcare (Germany), bioMérieux (France), Abbott Laboratories (U.S.), Novartis AG (Switzerland), Cepheid (U.S.), and Beckman Coulter (U.S.).
Browse related reports:
Diagnostic Electrocardiograph (ECG) Market by Product (Resting, Stress, Holter Monitor), End-user (Hospitals, Home/Ambulatory, Research Center, Physician Office, Nursing Homes) & by Lead Type (Single, 3-6, 12) - Global Forecast to 2020
http://www.marketsandmarkets.com/Market-Reports/Diagnostic-ECG-global-Market-173.html
Diagnostic Imaging Market by X-ray Systems (Digital, Analog, Portable), Computed Tomography, Ultrasound Imaging Systems (2D, 3D, 4D, Doppler), MRI Machines (Closed & Open), and Nuclear Imaging Systems (SPECT, PET, PET/CT) - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/diagnostic-imaging-market-411.html
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Molecular Diagnostics Market by Technology, Application & Product Will Reach $7,956.9 Million by 2018
Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018